These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

478 related items for PubMed ID: 27590191

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Prognostic value of bone marrow 18F-FDG uptake on PET/CT in lymphoma patients with negative bone marrow involvement.
    Lee JW, Lee SC, Kim HJ, Lee SM.
    Hell J Nucl Med; 2017; 20(1):17-25. PubMed ID: 28315904
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prognostic significance of bone marrow and spleen 18F-FDG uptake in patients with colorectal cancer.
    Lee JH, Lee HS, Kim S, Park EJ, Baik SH, Jeon TJ, Lee KY, Ryu YH, Kang J.
    Sci Rep; 2021 Jun 09; 11(1):12137. PubMed ID: 34108552
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
    Zhang H, Wroblewski K, Liao S, Kampalath R, Penney BC, Zhang Y, Pu Y.
    Acad Radiol; 2013 Jan 09; 20(1):32-40. PubMed ID: 22999369
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Prognostic value of bone marrow (18)F-FDG uptake pattern of pretreatment PET-CT in extranodal NK/T cell lymphoma].
    Zhang Y, Zhou J, Wang L, Li JY, Ding CY.
    Zhonghua Zhong Liu Za Zhi; 2020 Oct 23; 42(10):885-890. PubMed ID: 33113633
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Artificial intelligence-based, volumetric assessment of the bone marrow metabolic activity in [18F]FDG PET/CT predicts survival in multiple myeloma.
    Sachpekidis C, Enqvist O, Ulén J, Kopp-Schneider A, Pan L, Mai EK, Hajiyianni M, Merz M, Raab MS, Jauch A, Goldschmidt H, Edenbrandt L, Dimitrakopoulou-Strauss A.
    Eur J Nucl Med Mol Imaging; 2024 Jul 23; 51(8):2293-2307. PubMed ID: 38456971
    [Abstract] [Full Text] [Related]

  • 15. The predictive value of 18F-FDG PET-CT for assessing the clinical outcomes in locally advanced NSCLC patients after a new induction treatment: low-dose fractionated radiotherapy with concurrent chemotherapy.
    Mattoli MV, Massaccesi M, Castelluccia A, Scolozzi V, Mantini G, Calcagni ML.
    Radiat Oncol; 2017 Jan 05; 12(1):4. PubMed ID: 28057034
    [Abstract] [Full Text] [Related]

  • 16. Bone marrow hypermetabolism on 18F-FDG PET as a survival prognostic factor in non-small cell lung cancer.
    Prévost S, Boucher L, Larivée P, Boileau R, Bénard F.
    J Nucl Med; 2006 Apr 05; 47(4):559-65. PubMed ID: 16595487
    [Abstract] [Full Text] [Related]

  • 17. Prognostic value of 18F-fluorodeoxyglucose uptake in the bone marrow on pretreatment positron emission tomography/computed tomography in patients with esophageal cancer who underwent esophagectomy.
    Yoshida N, Eto K, Horinouchi T, Shiraishi S, Kanemitsu K, Ofuchi T, Tajiri T, Adachi Y, Horino T, Morito A, Mitsuura C, Maeda Y, Hara Y, Matsumoto C, Baba H.
    Esophagus; 2023 Oct 05; 20(4):660-668. PubMed ID: 37129700
    [Abstract] [Full Text] [Related]

  • 18. Prognostic significance of diffuse increased fluorine-18-fluorodeoxyglucose (18F-FDG) uptake within the reticuloendothelial system in lymphoma patients.
    Zhao Z, Zhou Y, Yao X, Ge S, Sang S, Yang Y, Zhang B, Deng S.
    Quant Imaging Med Surg; 2024 Sep 01; 14(9):6374-6385. PubMed ID: 39281118
    [Abstract] [Full Text] [Related]

  • 19. Are pretreatment 18F-FDG PET tumor textural features in non-small cell lung cancer associated with response and survival after chemoradiotherapy?
    Cook GJ, Yip C, Siddique M, Goh V, Chicklore S, Roy A, Marsden P, Ahmad S, Landau D.
    J Nucl Med; 2013 Jan 01; 54(1):19-26. PubMed ID: 23204495
    [Abstract] [Full Text] [Related]

  • 20. Potential role of pre-treatment bone marrow SUVmean to liver SUVmean ratio (BM/L) and comparison of primary tumour FDG uptake with brain FDG uptake in predicting survival in limited-stage lung cancers.
    Kavurgaci S, Özmen Ö, Tatci E, Söyler Y, Cengiz Tİ, Kabalak PA, Kizilgöz D, Yilmaz Ü.
    Nucl Med Commun; 2024 Jan 01; 45(1):77-85. PubMed ID: 37779431
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.